Atherosclerosis progression was more than twice as common in younger people with systemic lupus erythematosus (SLE) than in ...

Felzartamab is under clinical development by Biogen and currently in Phase I for Lupus Nephritis. According to GlobalData, Phase I drugs for Lupus Nephritis have an 84% phase transition success rate ...

CNTY-101 is under clinical development by Century Therapeutics and currently in Phase I for Lupus Nephritis. According to GlobalData, Phase I drugs for Lupus Nephritis have an 84% phase transition ...

A new study explored the potential of IncRNA CASC2 and miR-155 levels as non-invasive diagnostic biomarkers for systemic lupus erythematosus (SLE) and lupus nephritis (LN). Previous studies have found ...

Now, scientists at Stanford University have found that a faulty genetic molecule could be responsible for the immune system misidentifying healthy tissue as a threat. The breakthrough study, published ...

Delhi High Court recently ruled that medical negligence couldn't be proven solely through dissatisfaction or claims about ...

If reading about these atrocities churns your stomach, reflect on what is going on before our eyes these very days ...

Piper Sandler lowered the firm’s price target on Century Therapeutics (IPSC) to $4 from $12 and keeps an Overweight rating on the shares.

Give now and your generosity will be matched dollar for dollar up to $20,000! Your tax-deductible donation today will provide people with lupus the support and resources they need and help end this ...

An Oklahoma Medical Research Foundation physician-scientist is advancing research on a saliva test to diagnose Sjögren’s ...

Americans turned to Google with a wide range of health questions in 2024, a recent analysis found.

Through Dec. 20, the FDA approved 50 brand new medicines, defined as proteins, small molecules, or other chemicals this year.